Oxbridge is dedicated to market specialist in selected countries where health care budgets are highly constrained
Key Milestones

 

  • September 2002: Company incorporation

  • 2nd Quarter 2003: Arabian Alliance agreement in the Middle East 

  • 2nd Quarter 2004: 1st Plasma product introduced in the United Kingdom

  • 3rd Quarter 2006: 1st Biopharmaceutical product launch in the Middle East

  • 2nd Quarter 2007: 1st Plasma product launch in the Middle East 

  • 2nd Quarter 2009: 2nd Biopharmaceutical product launch in the Middle East 

  • 3rd Quarter 2011: 2nd Plasma product approved in UK